Safety and immunologic impact of neoadjuvant/adjuvant GVAX, cyclophosphamide, pembrolizumab, and anti-CSF1R agent IMC-CS4 in pancreatic adenocarcinoma
新辅助/辅助GVAX、环磷酰胺、帕博利珠单抗和抗CSF1R药物IMC-CS4在胰腺腺癌中的安全性和免疫学影响
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1715761
Urman, Arielle; Ding, Yingjun; Durham, Jennifer; Wang, Hao; Qi, Hanfei; Narang, Amol; Burkhart, Richard; He, Jin; Le, Dung; Laheru, Daniel; Thompson, Elizabeth; Jaffee, Elizabeth; Purtell, Katrina; Waisome-Stephens, Charmaine; Liu, Meizheng; Zheng, Lei; De Jesus-Acosta, Ana